Evidence map›Paper›PMID 34758301›Full record

ArticleCell reports2021

The hepatic compensatory response to elevated systemic sulfide promotes diabetes.

Roderick N Carter, Matthew T G Gibbins, Martin E Barrios-Llerena, Stephen E Wilkie, Lydia Freddolino, Marouane Libiad, Victor Vitvitsky, Barry Emerson, Thierry Le Bihan, Madara Brice and 19 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Hydrogen Sulfide Signaling in Neurodegenerative Movement Disorders.Handbook of experimental pharmacology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. The Role of Bacteria-Derived Hydrogen Sulfide in Multiple Axes of Disease.International journal of molecular sciences · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Cysteine as a Multifaceted Player in Kidney, theMolecules (Basel, Switzerland) · 2022
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 9 institutions in 5 countries.

Roderick N CarterUniversity/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.
Matthew T G GibbinsUniversity/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.
Martin E Barrios-LlerenaUniversity/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.
Stephen E WilkieUniversity/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK; Glasgow Ageing Research Network (GARNER), Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow G12 8QQ, UK.
Lydia FreddolinoDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Marouane LibiadDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Victor VitvitskyDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Barry EmersonUniversity/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.
Thierry Le BihanSynthSys - Systems and Synthetic Biology, Edinburgh EH9 3JD, UK.
Madara BriceUniversity/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.
Huizhong SuCancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XR, UK.
Scott G DenhamUniversity/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.
Natalie Z M HomerUniversity/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.
Clare Mc FaddenUniversity/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.
Anne TailleuxUniversité de Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U101-EGID, 59000, Lille, France.
Nourdine FaressePhysiogenex S.A.S, Prologue Biotech, 516 rue Pierre et Marie Curie, 31670 Labège, France.
Thierry SulpicePhysiogenex S.A.S, Prologue Biotech, 516 rue Pierre et Marie Curie, 31670 Labège, France.
Francois BriandPhysiogenex S.A.S, Prologue Biotech, 516 rue Pierre et Marie Curie, 31670 Labège, France.
Tom GillingwaterCollege of Medicine & Veterinary Medicine, University of Edinburgh, Old Medical School (Anatomy), Teviot Place, Edinburgh EH8 9AG, UK.
Kyo Han AhnDepartment of Chemistry, POSTECH, 77 Cheongam-Ro, Nam-Gu, Pohang, Gyungbuk 37673, South Korea.
Subhankar SinghaDepartment of Chemistry, POSTECH, 77 Cheongam-Ro, Nam-Gu, Pohang, Gyungbuk 37673, South Korea.
Claire McMasterSchool of Chemistry, Joseph Black Building, University of Glasgow, Glasgow G12 8QQ, UK.
Richard C HartleySchool of Chemistry, Joseph Black Building, University of Glasgow, Glasgow G12 8QQ, UK.
Bart StaelsUniversité de Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U101-EGID, 59000, Lille, France.
Gillian A GrayUniversity/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.
Andrew J FinchCancer Research UK Edinburgh Centre, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XR, UK.
Colin SelmanGlasgow Ageing Research Network (GARNER), Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow G12 8QQ, UK.
Ruma BanerjeeDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Nicholas M MortonUniversity/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK. Electronic address: nik.morton@ed.ac.uk.
British Heart Foundation · GBUniversity of Michigan · USPhysiogenex (France) · FRUniversity of Glasgow · GBInserm · FRPohang University of Science and Technology · KRWestern General Hospital · GBSynopsys (Switzerland) · CHUniversity of Edinburgh · GB

Funding

Sulfide Oxidation and SignalingR35GM130183 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUMA V BANERJEE · 2019 to 2026
$3.6M
Diabetes UK 17/0005697Medical Research Council MC-PC-15076Medical Research Council MC_PC_15076NIGMS NIH HHS R35 GM130183Wellcome TrustWellcome Trust 100981/Z/13/Z
6 · The paper itself

Abstract

Impaired hepatic glucose and lipid metabolism are hallmarks of type 2 diabetes. Increased sulfide production or sulfide donor compounds may beneficially regulate hepatic metabolism. Disposal of sulfide through the sulfide oxidation pathway (SOP) is critical for maintaining sulfide within a safe physiological range. We show that mice lacking the liver- enriched mitochondrial SOP enzyme thiosulfate sulfurtransferase (Tst

Indexed as

GluconeogenesisAnimalsDiabetes MellitusDyslipidemiasGlucoseLipid MetabolismLiverMaleMiceMice, Inbred C57BLMice, KnockoutNF-E2-Related Factor 2ProteomeSulfidesThiosulfate SulfurtransferaseGlucoseNfe2l2 protein, mouseNF-E2-Related Factor 2ProteomeSulfidesThiosulfate Sulfurtransferasefatty livergluconeogenesisinsulin sensitivitypersulfidationsulfidesulfide donorsulfide oxidation pathwaythiosulfate sulfur transferaseTSTtype 2 diabetes

Identifiers

PMID34758301
PMCPMC8595646
OpenAlexW3212461928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.